Tianjin First Center Hospital
In research, Tianjin First Center Hospital stands highest in Medicine (#1,987 of 10,443 worldwide), Health Sciences (#2,869 of 11,982 worldwide) and Life Sciences (#2,790 of 7,800 worldwide), 2022–2025. Relative to its size it is most specialised in Immunology, Oncology and Immunology and Microbiology — Immunology is 6.3× its share of world research.
- World rank, 2022–2025
- #5,611 of 28,054 · #12,140 all time
- Rank in China
- #1,204 of 3,058
- Research works
- 1.8k ▲ 26% vs 2013–17
- Citations
- 16k 8.8 per fractional work
- Top-10% rate
- 16.7% record average 16.5%
- Open access
- 41% world 28%
What is Tianjin First Center Hospital known for in research?
The fields where it stands highest, 2022–2025, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works | All time |
|---|---|---|---|---|---|
| MedicineField | #1,987 of 10,443 | 15.1% | 293 | #4746 | |
| Health SciencesDomain | #2,869 of 11,982 | 15.1% | 303 | #6163 | |
| Life SciencesDomain | #2,790 of 7,800 | 18.4% | 125 | #5801 | |
| Biochemistry, Genetics and Molecular BiologyField | #2,629 of 3,579 | 19.8% | 83 | #5357 |
Each strip is that field’s whole ranked pool, with the notch where Tianjin First Center Hospital sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
Which of those standings moved
The same fields on both windows: where it stood over the whole record, and where it stands in 2022–2025. The distance is the story, and it is the one thing the two rank columns above cannot show.
- Medicine#4,746 #1,987
- Health Sciences#6,163 #2,869
- Life Sciences#5,801 #2,790
- Biochemistry, Genetics and Molecular Biology#5,357 #2,629
A dot further right is a better standing. Fields it was not ranked in over the whole record are left out.
What does Tianjin First Center Hospital specialise in?
Where its research is concentrated relative to its size: Immunology takes 6.3× the share of its output that it takes of world research.
- ImmunologySubfield · 20.2 works6.3×
- OncologySubfield · 30.0 works5.7×
- Immunology and MicrobiologyField · 22.5 works4.8×
Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 4.8×. Every wedge is a field page.
- Immunology and Microbiology 4.8×
- Biochemistry, Genetics and Molecular Biology 3.4×
- Medicine 3.3×
- Neuroscience 2.0×
- Veterinary 1.5×
- Pharmacology, Toxicology and Pharmaceutics 1.4×
- Nursing 1.3×
- Dentistry 0.7×
- Materials Science 0.4×
- Health Professions 0.3×
- Chemistry 0.3×
- Engineering 0.2×
- Psychology 0.2×
- Chemical Engineering 0.1×
- Agricultural and Biological Sciences 0.1×
- Computer Science 0.1×
- Mathematics 0.1×
- Environmental Science 0.1×
- Physics and Astronomy 0.1×
- Economics, Econometrics and Finance 0.1×
- Earth and Planetary Sciences 0.0×
- Energy 0.0×
- Business, Management and Accounting 0.0×
- Social Sciences 0.0×
Which keywords describe research at Tianjin First Center Hospital?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Inflammation, Cancer, Oxidative Stress, Immunotherapy, Tumor Microenvironment, Epidemiology, Graft Survival and Metastasis.
- Liver Cirrhosis
- Macrophages
- Coagulopathy
- Chimeric Antigen Receptor
- Tumor Regression
- Hepatocellular Carcinoma
- Regulation
- Donor Risk Index
- Biogenesis
- Chemotherapy
- Lymphoma
- Ischemia-Reperfusion Injury
- Immunity
- Metabolic Syndrome
- Metastasis
- Treatment
- Graft Survival
- Tumor Microenvironment
- Oxidative Stress
- Cancer
- Inflammation
- Epidemiology
- Immunotherapy
- Cardiovascular Disease
- Biomarkers
- Gene Expression
- Liver Transplantation
- Diagnosis
- Cancer Immunotherapy
- Clinical Practice Guidelines
- Management
- Immune Response
- Biliary Complications
- Prognostic Factors
- Cell Death
- Insulin Resistance
- CAR T Cells
- Apoptosis
- Cancer Progression
- Hepatic Encephalopathy
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Inflammation46▲ 4.8×74 topics
- Cancer40▲ 6.4×52 topics
- Epidemiology36▲ 1.94×89 topics
- Oxidative Stress30▲ 3.9×46 topics
- Immunotherapy20▲ 6.2×17 topics
- Tumor Microenvironment17▲ 8.5×8 topics
- Cardiovascular Disease17▲ 3.3×31 topics
- Graft Survival16▲ 41×3 topics
- Biomarkers15▲ 4.8×14 topics
- Treatment15▲ 2.7×34 topics
- Gene Expression14▲ 5.0×12 topics
- Metastasis14▲ 8.8×12 topics
- Liver Transplantation14▲ 24×4 topics
- Metabolic Syndrome13▲ 3.5×21 topics
- Diagnosis13▲ 3.0×30 topics
- Immunity12▲ 6.6×10 topics
- Cancer Immunotherapy12▲ 17×3 topics
- Ischemia-Reperfusion Injury12▲ 40×3 topics
- Clinical Practice Guidelines12▲ 4.7×14 topics
- Lymphoma12▲ 16×3 topics
- Management12▲ 3.2×23 topics
- Chemotherapy11▲ 3.5×21 topics
- Immune Response11▲ 4.3×19 topics
- Biogenesis11▲ 13×3 topics
- Biliary Complications11▲ 56×1 topic
- Donor Risk Index11▲ 56×1 topic
- Prognostic Factors11▲ 5.3×14 topics
- Regulation11▲ 4.3×9 topics
- Cell Death10▲ 9.4×6 topics
- Hepatocellular Carcinoma10▲ 10×4 topics
- Insulin Resistance10▲ 4.5×8 topics
- Tumor Regression10▲ 19×2 topics
- CAR T Cells9▲ 27×1 topic
- Chimeric Antigen Receptor9▲ 27×1 topic
- Apoptosis9▲ 6.3×21 topics
- Coagulopathy8▲ 22×2 topics
- Cancer Progression8▲ 8.7×8 topics
- Macrophages8▲ 9.3×7 topics
- Hepatic Encephalopathy7▲ 29×1 topic
- Liver Cirrhosis7▲ 29×1 topic
Which research topics does Tianjin First Center Hospital publish most on?
By volume in 2022–2025: Organ Transplantation Techniques and Outcomes, CAR-T cell therapy research, Liver Disease and Transplantation and Ferroptosis and cancer prognosis.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Organ Transplantation Techniques and Outcomes Surgery 11 works
- 2 CAR-T cell therapy research Oncology 9 works
- 3 Liver Disease and Transplantation Hepatology 7 works
- 4 Ferroptosis and cancer prognosis Pulmonary and Respiratory Medicine 6 works
- 5 MicroRNA in disease regulation Cancer Research 5 works
- 6 Liver Disease Diagnosis and Treatment Epidemiology 5 works
- 7 Cancer-related molecular mechanisms research Cancer Research 5 works
- 8 Renal Transplantation Outcomes and Treatments Transplantation 4 works
- 9 Hepatocellular Carcinoma Treatment and Prognosis Hepatology 4 works
- 10 RNA modifications and cancer Molecular Biology 4 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Tianjin First Center Hospital's research output changed?
Output in 2018–2022 was 26% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Tianjin
- Tianjin University
- Nankai University
- Hebei University of Technology
- Tianjin University of Technology
- Tiangong University
- Tianjin Medical University
- Tianjin University of Science and Technology
- Civil Aviation University of China
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.